Using PRIME, we selected the top 80 predicted mutants for in vivo validation, with mutations primarily enriched in the RuvC and WED domains. Notably, these predictions aligned with findings from TnpB ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results